IDH1 and IDH2 Mutations in Gliomas

Yan, Hai, Parsons, D. Williams, Jin, Genglin, McLendon, Roger, Rasheed, B. Ahmed, Yuan, Weishi, Kos, Ivan, Batinic-Haberle, Ines +10 more·2009·New England Journal of Medicine

Cited by (1,012)

Items 1,001–1,012 of 1,012

  1. Interactions between epigenetics and metabolism in cancers
    Yun, Jihye, Johnson, Jared L., Hanigan, Christin L., Locasale, Jason W. · 2012 · Frontiers in Oncology
  2. A high-throughput fluorimetric assay for 2-hydroxyglutarate identifies Zaprinast as a glutaminase inhibitor
    Elhammali, Adnan, Ippolito, Joseph E., Collins, Lynne, Crowley, Jan, Marasa, Jayne, Piwnica-Worms, David · 2014 · Cancer Discovery
  3. 2-HG Inhibits Necroptosis by Stimulating DNMT1-Dependent Hypermethylation of the RIP3 Promoter
    Yang, Zhentao, Jiang, Bin, Wang, Yan, Ni, Hengxiao, Zhang, Jia, Xia, Jinmei, Shi, Minggang, Hung, Li-Man, Ruan, Jingsong, Mak, Tak Wah et al. · 2017 · Cell Reports
  4. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy
    Amoedo, N.D., Obre, E., Rossignol, R. · 2017 · Biochimica et Biophysica Acta (BBA) - Bioenergetics
  5. <i>IDH</i> Mutation Subgroup Status Associates with Intratumor Heterogeneity and the Tumor Microenvironment in Intrahepatic Cholangiocarcinoma
    Xiang, Xiao, Liu, Ziyang, Zhang, Chong, Li, Zhao, Gao, Jie, Zhang, Changkun, Cao, Qi, Cheng, Jinghui, Liu, Hengkang, Chen, Dingbao et al. · 2021 · Advanced Science
  6. Non-Invasive Tumor Genotyping Using Radiogenomic Biomarkers, a Systematic Review and Oncology-Wide Pathway Analysis
    Jansen, Robin W., van Amstel, Paul, Martens, Roland M., Kooi, Irsan E., Wesseling, Pieter, de Langen, Adrianus J., Menke-Van der Houven van Oordt, Catharina W., Jansen, Bernard H.E., Moll, Annette C., Dorsman, Josephine C. et al. · 2018 · Oncotarget
  7. Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations
    Figarella-Branger, D., Mokhtari, K., Dehais, C., Jouvet, A., Uro-Coste, E., Colin, C., Carpentier, C., Forest, F., Maurage, C.-A., Vignaud, J.-M. et al. · 2014 · Neuro-Oncology
  8. IDH2 and NPM1 Mutations Cooperate to Activate Hoxa9/Meis1 and Hypoxia Pathways in Acute Myeloid Leukemia
    Ogawara, Yoko, Katsumoto, Takuo, Aikawa, Yukiko, Shima, Yutaka, Kagiyama, Yuki, Soga, Tomoyoshi, Matsunaga, Hironori, Seki, Takahiko, Araki, Kazushi, Kitabayashi, Issay · 2015 · Cancer Research
  9. Biologically interpretable multi-task deep learning pipeline predicts molecular alterations, grade, and prognosis in glioma patients
    Wu, Xuewei, Zhang, Shuaitong, Zhang, Zhenyu, He, Zicong, Xu, Zexin, Wang, Weiwei, Jin, Zhe, You, Jingjing, Guo, Yang, Zhang, Lu et al. · 2024 · npj Precision Oncology
  10. IDH1 Mutation Promotes Tumorigenesis by Inhibiting JNK Activation and Apoptosis Induced by Serum Starvation
    Jiang, Bin, Zhang, Jia, Xia, Jinmei, Zhao, Wentao, Wu, Yanan, Shi, Minggang, Luo, Lianzhong, Zhou, Huamin, Chen, Ai, Ma, Huanhuan et al. · 2017 · Cell Reports
  11. Wilms Tumor in a Child with L-2-hydroxyglutaric Aciduria
    Rogers, Robert E., DeBerardinis, Ralph J., Klesse, Laura J., Boriack, Richard L., Margraf, Linda R., Rakheja, DINESH · 2010 · Pediatric and Developmental Pathology
  12. Indications for Treatment: Is Observation or Chemotherapy Alone a Reasonable Approach in the Management of Low-Grade Gliomas?
    Schaff, Lauren R., Lassman, Andrew B. · 2015 · Seminars in Radiation Oncology